Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Dhanunjaya Lakkireddy Added: 2 years ago
AFSymposium 2024 — In this interview, investigator, Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute, US) shares the key findings from the aMAZE Continued Access Protocol (AtriCure).This study is the extension of the aMAZE Trial investigation in the form of a nested, non-randomised registry. The study looked at the LARIAT System, which percutaneously isolates and ligates the left… View more
Added: 3 months ago Source:  Radcliffe Cardiology
A novel nanosecond pulsed field ablation (nsPFA) system has demonstrated noninferior efficacy and comparable safety to conventional ablation index (AI)-guided radiofrequency ablation (RFA) for treating paroxysmal atrial fibrillation (AF), according to results from the InsightPFA trial.¹ The study also highlights that the procedure can be performed under conscious sedation, potentially… View more
Author(s): Tobias Reichlin Added: 2 years ago
ESC 2023 — Dr Tobias Reichlin (Inselspital, University of Bern, CH) joins us on-site at ESC 2023 to discuss the findings of the COMPARE-CRYO Trial (NCT04704986). The COMPARE-CRYO trial (Insel Gruppe AG, University Hospital Bern) aimed to compare the safety and efficacy of the PolarX Cryoballoon (Boston Scientific) with the Arctic Front Cryoballoon (Medtronic) in patients with symptomatic… View more
Author(s): Vivek Reddy Added: 3 weeks ago
AF Symposium 2026 - Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, New York, NY, US) joins us to discuss findings from the ADVENT LTO study, evaluating long-term outcomes and atrial fibrillation progression in patients who received ablation with the FARAPULSE Pulsed Field Ablation System compared to thermal ablation.The study tracked AF progression patterns, arrhythmia recurrence rates,… View more
Author(s): Atul Verma Added: 3 weeks ago
Dr Atul Verma (McGill University Health Centre & McGill University, Montreal, CA, US) joins us to discuss findings from the VOLT AF IDE trial, evaluating a novel balloon-in-basket pulsed field ablation system that integrates mapping and ablation capabilities.The prospective, multicenter VOLT AF IDE study evaluated safety and effectiveness of the Volt™ PFA system in patients with symptomatic,… View more